ID
35684
Beschreibung
Study ID: 101468/192 Clinical Study ID: 101468/192 Study Title:A 52 Week Open-Label Extension Study of the Long-Term Safety of Ropinirole in Subjects Suffering from Restless Legs Syndrome (RLS) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Restless Legs Syndrome The study consists of 16 visits which are devided in 3 study books: Book 1: Screening (+Baseline), Day 2, Week 1, Week 2 , Week 3 , Week 4, Week 5, Week 6, Week 7, Week 8 Book 2: Week 12, Week 24, Week 36, Week 48, Week 52, Follow-up Book 3: Early withdrawal and Follow-up Each follow-up Visit takes place 7 +/- 3 days after last dose This document contains the Study Medication And Compliance Record form. It has to be filled in for each Visit. It also cntains the Dose reduction due to AE form. It has to be filled in for Week 12-48 and Follow-up.
Stichworte
Versionen (1)
- 15.03.19 15.03.19 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
15. März 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Long-Term Safety of Ropinirole in Subjects Suffering from Restless Legs Syndrome (RLS), 101468/192
Study Medication And Compliance Record, Dose reduction due to AE
- StudyEvent: ODM
Beschreibung
Study Medication And Compliance Record
Alias
- UMLS CUI-1
- C2734539
- UMLS CUI-2
- C0008972
- UMLS CUI-3
- C1321605
Beschreibung
Week Number
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0439230
- UMLS CUI [1,2]
- C0237753
Beschreibung
Dose Level
Datentyp
integer
Alias
- UMLS CUI [1]
- C0178602
Beschreibung
day month year
Datentyp
date
Alias
- UMLS CUI [1]
- C3173309
Beschreibung
day month year
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0178602
- UMLS CUI [1,2]
- C1517741
- UMLS CUI [1,3]
- C0011008
Beschreibung
Number of tablets dispensed
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0805077
- UMLS CUI [1,2]
- C0304229
Beschreibung
Number of tablets returned
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C2699071
- UMLS CUI [1,2]
- C0304229
Beschreibung
Dose Reductions Due to Adverse Experiences
Alias
- UMLS CUI-1
- C1707814
- UMLS CUI-2
- C0559546
Beschreibung
Week
Datentyp
integer
Alias
- UMLS CUI [1]
- C0439230
Beschreibung
Dose Level
Datentyp
integer
Alias
- UMLS CUI [1]
- C0178602
Beschreibung
day month year
Datentyp
date
Alias
- UMLS CUI [1]
- C3173309
Beschreibung
day month year
Datentyp
date
Alias
- UMLS CUI [1,1]
- C0178602
- UMLS CUI [1,2]
- C1517741
- UMLS CUI [1,3]
- C0011008
Beschreibung
Number of tablets dispensed
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C0805077
- UMLS CUI [1,2]
- C0304229
Beschreibung
Number of tablets returned
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C2699071
- UMLS CUI [1,2]
- C0304229
Ähnliche Modelle
Study Medication And Compliance Record, Dose reduction due to AE
- StudyEvent: ODM
C0019994 (UMLS CUI [1,2])
C0008972 (UMLS CUI-2)
C1321605 (UMLS CUI-3)
C0237753 (UMLS CUI [1,2])
C1517741 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
C0559546 (UMLS CUI-2)
C1517741 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0304229 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,2])
Keine Kommentare